# FDA recall D-0135-2025

> **Mylan Institutional, Inc.** · Class II · drug recall initiated 2024-11-19.

## Product

Levothyroxine Sodium Tablets, USP, 150 mcg (0.150 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA.  NDC: 51079-445-20

## Reason for recall

Subpotent and Superpotent Drug

## Distribution

Nationwide in the USA.

## Key facts

- **Recall number:** D-0135-2025
- **Recalling firm:** Mylan Institutional, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2024-11-19
- **Report date:** 2024-12-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Rockford, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0135-2025

## Citation

> AI Analytics. FDA recall D-0135-2025. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0135-2025. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*